Cite
HARVARD Citation
Greten, T. et al. (n.d.). 2259 Tremelimumab - A monoclonal antibody against CTLA-4 - in combination with local tumor ablation (TACE or RFA) in patients with hepatocellular carcinoma (HCC). European journal of cancer. pp. S419-. [Online].